Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 117

1.

Efficacy of desloratadine, 5 mg, compared with fexofenadine, 180 mg, in patients with symptomatic seasonal allergic rhinitis.

Berger WE, Lumry WR, Meltzer EO, Pearlman DS.

Allergy Asthma Proc. 2006 May-Jun;27(3):214-23.

PMID:
16913264
2.
3.
5.

Safety and efficacy of desloratadine 5 mg in asthma patients with seasonal allergic rhinitis and nasal congestion.

Berger WE, Schenkel EJ, Mansfield LE; Desloratadine Study Group..

Ann Allergy Asthma Immunol. 2002 Nov;89(5):485-91.

PMID:
12452207
7.

Effects of fexofenadine and desloratadine on subjective and objective measures of nasal congestion in seasonal allergic rhinitis.

Wilson AM, Haggart K, Sims EJ, Lipworth BJ.

Clin Exp Allergy. 2002 Oct;32(10):1504-9.

PMID:
12372132
8.

Efficacy and safety of desloratadine/pseudoephedrine combination vs its components in seasonal allergic rhinitis.

Grubbe RE, Lumry WR, Anolik R.

J Investig Allergol Clin Immunol. 2009;19(2):117-24.

9.

Comparative effects of desloratadine versus montelukast on asthma symptoms and use of beta 2-agonists in patients with seasonal allergic rhinitis and asthma.

Baena-Cagnani CE, Berger WE, DuBuske LM, Gurné SE, Stryszak P, Lorber R, Danzig M.

Int Arch Allergy Immunol. 2003 Apr;130(4):307-13.

PMID:
12740532
10.
11.

Efficacy of diphenhydramine vs desloratadine and placebo in patients with moderate-to-severe seasonal allergic rhinitis.

Raphael GD, Angello JT, Wu MM, Druce HM.

Ann Allergy Asthma Immunol. 2006 Apr;96(4):606-14.

PMID:
16680933
12.

Efficacy of fexofenadine versus desloratadine in suppressing histamine-induced wheal and flare.

Meltzer EO, Gillman SA.

Allergy Asthma Proc. 2007 Jan-Feb;28(1):67-73.

PMID:
17390761
13.

Efficacy and safety of desloratadine in the treatment of perennial allergic rhinitis.

Simons FE, Prenner BM, Finn A Jr; Desloratadine Study Group..

J Allergy Clin Immunol. 2003 Mar;111(3):617-22.

PMID:
12642846
14.

Fexofenadine is efficacious and safe in children (aged 6-11 years) with seasonal allergic rhinitis.

Wahn U, Meltzer EO, Finn AF Jr, Kowalski ML, Decosta P, Hedlin G, Scheinmann P, Bachert C, Rosado Pinto JE, Baena-Cagnani C, Potter P, Simons FE, Ruuth E.

J Allergy Clin Immunol. 2003 Apr;111(4):763-9. Erratum in: J Allergy Clin Immunol. 2003 Dec;112(6):1202. J Allergy Clin Immunol. 2003 Jul;112(1):71.

PMID:
12704355
15.

Safety and efficacy of desloratadine in subjects with seasonal allergic rhinitis or chronic urticaria: results of four postmarketing surveillance studies.

Bachert C, Maurer M.

Clin Drug Investig. 2010;30(2):109-22. doi: 10.2165/11530930-000000000-00000. Review.

PMID:
20067329
16.

Comparison of the combinations of fexofenadine-pseudoephedrine and loratadine-montelukast in the treatment of seasonal allergic rhinitis.

Moinuddin R, deTineo M, Maleckar B, Naclerio RM, Baroody FM.

Ann Allergy Asthma Immunol. 2004 Jan;92(1):73-9.

PMID:
14756468
17.

Fexofenadine hydrochloride, 180 mg, exhibits equivalent efficacy to cetirizine, 10 mg, with less drowsiness in patients with moderate-to-severe seasonal allergic rhinitis.

Hampel F, Ratner P, Mansfield L, Meeves S, Liao Y, Georges G.

Ann Allergy Asthma Immunol. 2003 Oct;91(4):354-61.

PMID:
14582814
18.

Efficacy of desloratadine in intermittent allergic rhinitis: a GA(2)LEN study.

Bousquet J, Bachert C, Canonica GW, Mullol J, Van Cauwenberge P, Bindslev Jensen C, Fokkens WJ, Ring J, Keith P, Lorber R, Zuberbier T; ACCEPT-1 study group..

Allergy. 2009 Oct;64(10):1516-23. doi: 10.1111/j.1398-9995.2009.02115.x. Epub 2009 Jul 14.

19.

Systematic review on the efficacy of fexofenadine in seasonal allergic rhinitis: a meta-analysis of randomized, double-blind, placebo-controlled clinical trials.

Compalati E, Baena-Cagnani R, Penagos M, Badellino H, Braido F, Gómez RM, Canonica GW, Baena-Cagnani CE.

Int Arch Allergy Immunol. 2011;156(1):1-15. Review.

PMID:
21969990

Supplemental Content

Support Center